Noval, Teofila .
HRN: 03-10-79 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/20/2026
CEFUROXIME 1.5GM (VIAL)
03/20/2026
03/27/2026
IV
1.5G
Q8H
INFECTIOUS DIARRHEA
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: